by UT Southwestern Medical Center The binding of CTLA-4 antibodies throughout the body limits their anti-tumor effect. In contrast, a newly developed two-armed molecule that targets both CLTA-4 and CD47 on regulatory T cells efficiently hones in on tumors and enhances antitumor immunity. Credit: UT Southwestern Medical Center A two-arm molecule can effectively deplete cancer-protecting cells...
